Attached files
EXHIBIT
32.1
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY
ACT OF 2002
In
connection with the accompanying Quarterly Report on Form 10-Q of Caraco
Pharmaceutical Laboratories, Ltd. (“Caraco”) for the period ended December 31,
2009 (the “Report”), the undersigned hereby certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, to the best of their respective knowledge and belief, that:
(1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of Caraco.
/s/ Jitendra N. Doshi
|
||
Jitendra
N. Doshi
|
||
Chief
Executive Officer
|
||
/s/ Mukul Rathi
|
||
Mukul
Rathi
|
||
interim
Chief Financial Officer
|
Date: February
12, 2010